Glycans in Diseases & Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a mechanism employed by cells of the immune system via sugar-binding proteins called lectins, which recognize specific carbohydrate moieties. Glycans (carbohydrate oligomers) are the “building blocks” of carbohydrates, nucleic acids, proteins and lipids which play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology or glycochemistry approach to be used.

 

  • Congenital disorders of glycosylation (CDG)
  • Transfusion medicine
  • Glycomedicine
  • Cardiac arrest
  • Cancer associated coagulopathies
  • Cardiovascular diseases
  • Cancer biomarkers

Related Conference of Glycans in Diseases & Therapeutics

June 13-14, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
July 11-12, 2024

6th International Conference on Biochemistry

Paris, France
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Glycans in Diseases & Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in